Criteria
Eligible Active Ingredient: | Esomeprazole. As an oral solid preparation not exceeding 20mg |
With Effective From: | 1-Dec-16 |
Indication Permitted: | Relief of heartburn symptoms associated with acid reflux |
Maximum Daily Dose: | 20mg |
Maximum Supply per Transaction: | 2 weeks |
Minimum Age of User: | 18 years |
Patient Information Leaflet from HSA/PSS: | Download PIL (Link to HSA website) |
Mechanism of Action of Esomeprazole
Esomeprazole is a proton pump inhibitor that suppresses gastric acid secretion by specific inhibition of the H+/K+-ATPase in the gastric parietal cell. By acting specifically on the proton pump, Esomeprazole blocks the final step in acid production, thus reducing gastric acidity.
Additional Information of Esomeprazole
Pharmacology Class: | Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) |
Therapeutic Class: | Drugs For Acid Related Disorders |
Chemical Class: | Proton Pump Inhibitors |
Synonyms: | (−)-omeprazole | (S)-(−)-omeprazole | (S)-omeprazole | Esomeprazol | Ésoméprazole | Esomeprazolum | Omeprazole S-form | Perprazole |
Show All HSA-registered therapeutic products granted exemption to supply without prescription
References
HSA-Registered Products Containing Esomeprazole As an oral solid preparation not exceeding 20mg
wpDataTable with provided ID not found!
This list is not exhaustive. HSA collaborates with Pharmaceurical Society of Singapore (PSS) to review the appropriate use of therapeutic products in the community from time to time. Hence, HSA may enable the supply of a Prescription Only Medicine (POM) by pharmacists without a prescription, upon review that the product can be used in a safe and effective manner under the supervision of a pharmacist. This can be effected through legislative mechanisms in the absence of an application made by the product registrant to reclassify the therapeutic product, subject to to conditions including indication, strength, maximum daily dose, maximum supply quantity, and age restriction.